Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Avelumab approved for MCC.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): SCHIESZER, JOHN
- Source:
Dermatology Times. May2017, Vol. 38 Issue 5, p68-76. 3p.
- Additional Information
- Subject Terms:
- Abstract:
The article reports that the U.S. Food and Drug Administration (FDA) has approved the use of the drug avelumab (Bavencio) for treating adults and pediatric patients with metastatic Merkel cell carcinoma (MCC), as of May 2017. Topics discussed include how avelumab works, the efficacy of avelumab, and adverse effects of the drug.
No Comments.